|
Abstract
|
OBJECTIVE : To our knowledge, no studies have considered whether neuropsychological performance moderates the relationship between Holtzworth-Munroe and Stuart's intimate partner violence against women (IPVAW) perpetrator typologies and treatment compliance and recidivism. Therefore, we first aimed to assess whether the typologies show differences in specific neuropsychological variables such as cognitive flexibility and emotion decoding processes. Second, we also assessed whether there are differences in treatment compliance and recidivism between the IPVAW perpetrator typologies, based on their neuropsychological performance.
METHOD : We administered a set of neuropsychological tests and self-reports to a group of IPVAW perpetrators (n = 424). We also assessed their treatment compliance (i.e., dropout and intervention dose) and recidivism (i.e., risk of recidivism and official recidivism) after treatment.
RESULTS : Our analysis revealed that the family only (FO) perpetrators showed the best cognitive performance, followed by the borderline/dysphoric (BD) group, with the generally violent-antisocial (GVA) group showing the worst performance. Even though there were significant differences between the IPVAW perpetrators' typologies in their treatment compliance, and the recidivism, these differences were more pronounced when considering IPVAW perpetrators' typologies along with neuropsychological performance. That is, FO with high cognitive functioning presented the highest treatment compliance and lowest rates of recidivism. Conversely, GVA with low cognitive functioning presented the lowest treatment compliance and highest rate of recidivism.
CONCLUSIONS : Our study highlights the need to design therapeutic programs with coadjutant neuropsychological training to attend not only to the psychological needs of IPVAW perpetrators, but also to the neuropsychological deficits that might facilitate lower treatment compliance and recidivism. (PsycInfo Database Record (c) 2021 APA, all rights reserved)
Language: en |